The NaGdF4 ND@HAs have held great potential as an excellent MR contrast agent for detection CD44-overexpression tumor since advantages of NaGdF4 ND@HAs including high tumor targeting ability, efficient renal clearance capacity and excellent biocompatibility satisfied the basic standards of clinical applications. This evidence concerns the gene CD44 and neoplasm.